Human Resources
AbbVie, Medtronic and Pfizer crowned Best Workplaces for Women

AbbVie, Medtronic and Pfizer are the only companies from the pharma and medtech sectors named in the 2026 list of Australia’s Best Workplaces for Women.
Their recognition among 50 organisations nationwide sends a clear signal that high performance and gender equity are not competing priorities. They are business imperatives that must advance together.
“These companies aren’t marking their own homework – the bar is genuinely high,” said Rebecca Moulynox, General Manager of Great Place To Work Australia and New Zealand. “This list only champions employers that back their commitments on flexibility, fair pay and women in leadership with real numbers and real experiences.”
For AbbVie, the recognition reflects a culture built with intention.
Ally Jonas, HR Director, AbbVie ANZ, said “Creating an environment where women are genuinely empowered, respected, and given equal opportunities is at the core of our culture. Being named one of the Best Workplaces for Women in 2026 reaffirms our dedication to fostering an inclusive workplace where every woman’s ideas, ambitions, and achievements are celebrated and supported.”
At Pfizer, equity is framed as a defining value shaping leadership, engagement and long-term impact.
“Equity is one of Pfizer’s core values, grounded in our belief that every individual deserves to be seen, heard and genuinely cared for,” said Vanessa Armstrong, People Experience Lead, Pfizer Australia & New Zealand. “Guided by this value, we are committed to fostering a fair, inclusive and highly engaged workforce where people can thrive. This achievement reinforces our long-term commitment to meaningful, sustained progress – creating not only a fairer workplace, but contributing to a more equitable society overall.”
The results speak directly to outcomes that matter. According to Great Place To Work, women in top-ranked organisations are twice as likely to say they have an equal opportunity to grow their careers and three times more likely to describe their leaders as fair and inclusive.
“These workplaces aren’t just waiting for equity to happen,” said Moulynox. “They’ve embedded fairness into everyday decision-making, creating cultures where flexibility, psychological safety, and growth opportunities are pillars of performance.”
Liz Carnabuci, Vice President and Managing Director, Medtronic Australia and New Zealand, told Health Industry Hub, “We know that innovation and impact are strongest when women are supported to thrive at every stage of their careers. Being recognised as one of Australia’s Best Workplaces for Women 2026 is an honour, and we’re especially proud to be the only MedTech company included in the list.”
“This recognition reflects the voices of our people and our ongoing commitment to building an inclusive culture through grassroot initiatives like EmpowerME and our female career development programs – designed to create opportunity, zero barriers to equity and help women lead with confidence,” she added.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals
Inside the tensions shaping PBAC decisions
The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]
MoreNews - MedTech & Diagnostics
GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda
GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]
MoreNews - MedTech & Diagnostics
MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy
The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]
MoreNews - Pharmaceuticals
New breast cancer drug fills gap left by Zoladex market withdrawal
From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]
More